Loading clinical trials...
Loading clinical trials...
Educational Programs Based on Healthy Habits to Improve Quality of Life and Psychosocial Profile in Women With Neurodegenerative Diseases: The ADVICE Protocol Study
This phase of the project aims to compare in-person, supervised educational programs (EP) with online self-guided EPs in individuals with relapsing-remitting multiple sclerosis. A total of 75 participants will be randomly assigned to one of three groups: a supervised and individualized educational program focused on HIIT training, a supervised and individualized educational program focused on strength training, and a non-supervised, self-guided educational program based on resistance band training. Additionally, sessions on the Mediterranean diet (both supervised and non-supervised) and cognitive-behavioral interventions will be included. A control evaluation will be conducted three months after the intervention to assess the effects of the educational programs, followed by another evaluation three months later to analyze residual effects. Women who participated in Phase 1 of the study will be invited to take part in this second phase.
Age
18 - 50 years
Sex
ALL
Healthy Volunteers
No
Hospital Universitario Virgen de la Arrixaca
Murcia, Murcia, Spain
Start Date
April 15, 2025
Primary Completion Date
June 15, 2025
Completion Date
February 28, 2026
Last Updated
December 17, 2025
60
ESTIMATED participants
Strength training, nutrition, and behavioral training
OTHER
Self-Guided and Unsupervised Program with General Recommendations
OTHER
Lead Sponsor
Universidad de Almeria
Collaborators
NCT07376772
NCT06925022
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT07233902